Thomas Steyer’s Curis CRIS Stock Holding History

Thomas Steyer’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,500	Closed	-$11.3M	–	304
2021 Q1	$11.3M	Buy	2,500 +687	+38%	+$2.87M	0.06%	131
2020 Q4	$5.94M	Buy	+1,813	New	+$2.18M	0.04%	118

Other funds holding CRIS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Thomas Steyer's CRIS Position: Q2 2021 in Review

Thomas Steyer sold out of Curis (CRIS) in Q2 2021, closing a stake of 2,500 shares — an estimated $11.3M sold.

Thomas Steyer first reported a position in CRIS in Q4 2020 and held it in 2 quarters. The position peaked at $11.3M in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

Thomas Steyer reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
Thomas Steyer sold 2,500 Curis shares in Q2 2021, an estimated $11.3M.
Thomas Steyer first reported a position in Curis in Q4 2020 and held it in 2 quarters.
Thomas Steyer's Curis position peaked at $11.3M in Q1 2021.
127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.